Sec Form 4 Filing - AKKARAJU SRINIVAS @ Versartis, Inc. - 2017-03-24

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person AKKARAJU SRINIVAS 2. Issuer Name and Ticker or Trading Symbol Versartis, Inc. [ VSAR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O VERSARTIS, INC., 4200 BOHANNON DRIVE, SUITE 250 3. Date of Earliest Transaction (MM/DD/YY) 03/24/2017 (Street) MENLO PARK, CA94025 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/24/2017 P 571,429 ( 1 ) ( 2 ) A $ 12.25 571,429 I By Partnership ( 3 ) Common Stock 0 I By LLC ( 1 ) ( 2 ) Common Stock 11,475 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other AKKARAJU SRINIVAS C/O VERSARTIS, INC. 4200 BOHANNON DRIVE, SUITE 250 MENLO PARK, CA94025 X Signatures /s/ Srinivas Akkaraju 03/28/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These shares were purchased from SMM SPV I, LLC ("SMM SPV") pursuant to an agreement between SMM SPV and Samsara BioCapital, L.P. ("Samsara BioCapital"), to acquire such shares at the price paid for such shares by SMM SPV on October 3, 2016. The Reporting Person is the sole member and manager of Samsara BioCapital, LLC, the manager of SMM SPV, and had sole voting and dispositive power over the shares held by SMM SPV. The Reporting Person previously reported beneficial ownership of such shares indirectly through SMM SPV, disclaiming beneficial ownership of these shares except to the extent of his pecuniary interest therein. ( 2 )For purposes of Section 16, the purchase of these shares by Samsara BioCapital from SMM SPV constituted (i) a change in the form of ownership of the shares previously beneficially owned by the Reporting Person through SMM SPV from one form of indirect ownership to another; and (ii) with respect to the remaining shares acquired from SMM SPV, a purchase by the Reporting Person, in each case to the extent of his pecuniary interest in Samsara BioCapital. Following this transaction, SMM SPV no longer holds any securities of the Issuer. ( 3 )Shares held by Samsara BioCapital. The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these shares except to the extent of the Reporting Person's pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.